BidaskClub upgraded shares of iKang Healthcare Group, Inc. (NASDAQ:KANG) from a strong sell rating to a sell rating in a research report sent to investors on Saturday morning.

Shares of iKang Healthcare Group (NASDAQ KANG) traded up 3.45% during midday trading on Friday, hitting $13.80. 531,529 shares of the stock were exchanged. iKang Healthcare Group has a 12 month low of $11.70 and a 12 month high of $19.23. The company’s market cap is $890.79 million.

iKang Healthcare Group (NASDAQ:KANG) last posted its quarterly earnings results on Thursday, June 22nd. The medical research company reported ($0.49) EPS for the quarter. The company had revenue of $60.16 million during the quarter. iKang Healthcare Group had a negative return on equity of 3.19% and a negative net margin of 2.58%. On average, equities analysts anticipate that iKang Healthcare Group will post $0.65 earnings per share for the current year.

WARNING: “iKang Healthcare Group, Inc. (KANG) Upgraded to Sell by BidaskClub” was reported by Daily Political and is owned by of Daily Political. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/08/06/ikang-healthcare-group-inc-kang-upgraded-to-sell-by-bidaskclub.html.

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. First Manhattan Co. increased its position in iKang Healthcare Group by 101.7% in the second quarter. First Manhattan Co. now owns 1,040,043 shares of the medical research company’s stock valued at $12,761,000 after buying an additional 524,318 shares in the last quarter. Athos Capital Ltd bought a new position in iKang Healthcare Group during the second quarter valued at approximately $8,622,000. Finally, SG Americas Securities LLC increased its position in iKang Healthcare Group by 14.6% in the second quarter. SG Americas Securities LLC now owns 44,608 shares of the medical research company’s stock valued at $547,000 after buying an additional 5,700 shares in the last quarter. 29.79% of the stock is currently owned by institutional investors.

iKang Healthcare Group Company Profile

iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.

Receive News & Ratings for iKang Healthcare Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.